Net Income

Out of 600+ plans, Alignment Health is one of just four to earn a top award for medication quality. Here's what that means for seniors and the industry.

Edesa Biotech pushes its pipeline forward with a new vitiligo trial and promising ARDS data, but rising R&D costs highlight the high stakes of innovation.

The chip equipment giant posts record Q2 revenue and profit, driven by surging AI demand, and unveils major partnerships to accelerate future tech.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

As the healthcare industry bleeds talent, PruittHealth's fifth consecutive 'Great Place to Work' award reveals its culture-first strategy for retention and growth.

A novel device that treats hypertension from outside the artery shows early promise, challenging market leaders and offering new hope for millions.

A local partnership's stunning success in reducing infant mortality is gaining national attention, offering a blueprint for how to save mothers and babies.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

As GAAD marks 15 years, Level Access democratizes training to bridge the digital divide, proving accessibility is no longer just a cause, but a revenue driver.

A new prop firm says its capital-backed framework will ensure sustainable trader payouts, aiming to bring a new standard of transparency to the industry.

The Nexus Forum launches to connect China's booming biotech scene with global pharma, capitalizing on a major shift in worldwide drug discovery and deal-making.

NFL legend Brett Favre reports gains from an experimental Parkinson's drug, but what does the science say about this potential breakthrough treatment?

With the hire of veteran Sarah Schmitz, Balefire Wealth signals a major strategic expansion into the complex world of corporate retirement consulting.

Former Trump official Peter O'Rourke joins AI defense firm Quantum Cyber, a move signaling a major push for government contracts in autonomous warfare.

An ambitious challenge aims to turn Amazon biodiversity into sustainable businesses, betting that entrepreneurship is the key to the rainforest's survival.

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

Industry titans from Manchester United to DraftKings will convene to map out the future of streaming, gaming, and sports in a shifting regulatory landscape.

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

SoundThinking hires Mark43 veteran David Jochim to lead its TechnoLogic division, signaling a strategic push for operational excellence and delivery.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.